DIMS glasses
DeviceMyopia control glasses with peripheral defocus control design.
NCT Number: NCT07642934
The goal of this clinical trial is to compare the efficacy of myopia control lenses with different working principles in patients with intermittent exotropia aged 6 to 12 years. The main questions it aims to answer are:
Are there any differences in the clinical outcomes of DIMS and DOT glasses between children with intermittent exotropia and those with simple myopia (without intermittent exotropia)? Do DIMS and DOT glasses differ in their myopia control efficacy among children with intermittent exotropia? Does wearing DIMS or DOT glasses affect the binocular visual function of children with intermittent exotropia?
Trial opening soon.
Get Notified6 year–12 year
All sexes
Interventional
Not applicable
Intermittent exotropia (IXT) is a common ophthalmic disorder. It is clinically characterized by outward deviation of the eye position when patients fixate on distant targets, feel fatigued, or become inattentive. This condition impairs stereoscopic vision and visual quality, and may further deteriorate binocular fusion function, thereby considerably interfering with daily activities. Epidemiological data indicate that the prevalence of intermittent exotropia is approximately 4.7% in Asian populations. In China, it accounts for 75.64% of all strabismus cases, ranking first among all types of strabismus. Notably, more than 50% of children with intermittent exotropia are affected by myopia. Several studies suggest that these two conditions may share common pathogenetic mechanisms and present as comorbid disorders.
Currently, the mainstream designs of myopia control glasses are based on two core principles: peripheral defocus control and diffusion optics technology. Peripheral defocus glasses induce myopic defocus by refracting peripheral light to focus in front of or on the retina, which inhibits excessive axial elongation. Lenses adopting diffusion optics technology reduce the contrast of peripheral retinal images via microstructural design, so as to slow myopia progression. A number of clinical trials have verified the favorable efficacy of both lens types for myopia control in general children.
Nevertheless, systematic controlled studies comparing the myopia control effects between the two types of glasses in myopic children with concomitant intermittent exotropia remain scarce. Therefore, this comparative study focusing on this specific population possesses important clinical value and can also provide theoretical evidence for the formulation of individualized myopia management strategies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Myopia control glasses with peripheral defocus control design.
Myopia control glasses with diffusion optics technology.
Time frame: From enrollment to the end of follow-up at 1 year
Measurement Tool: IOL Master 700 (Carl Zeiss Meditec AG, Jena, Germany), a high-resolution swept-source optical coherence tomography (SS-OCT) device for biometric measurement of the eye Measurement Type: Continuous parameters of ocular biometry, mainly including axial length, anterior chamber depth, lens thickness, vitreous depth and other axial dimensional parameters of the eye
Unit of Measure:
Ocular axial length (AL): Millimeters (mm) Anterior chamber depth (ACD): Millimeters (mm) Lens thickness (LT): Millimeters (mm) Vitreous chamber depth (VCD): Millimeters (mm)
Time frame: From enrollment to the end of follow-up at 1 year
Equipment: Cyclopentolate 1%, trial frame, standard trial lens set and logarithmic visual acuity chart for clinical refractive examination Test condition: Completed cycloplegia with cyclopentolate (C) before examination Procedure: The child wears appropriate refractive correction as required. Conduct subjective refraction step by step to determine spherical power, cylindrical power and astigmatic axis. Adjust lenses continuously until the child achieves the clearest and most comfortable vision, then record all refractive parameters and best corrected visual acuity.
Time frame: From enrollment to the end of follow-up at 1 year
Distant stereoacuity:
Equipment: Random Dots Distant Test (P/N 1006, Vision Assessment Corporation, Illinois, USA) Test distance: 3 meters Range: 63 to 400 arcseconds (log stereoacuity: 1.8 to 2.6 log arcsec) Procedure: The subject identifies stereoscopic shapes at 3 meters. If unable to identify shapes at the 400 arcsec level, record as "nil stereo" (log stereoacuity value: 3.2 log arcsec).
Near stereoacuity:
Equipment: Randot Preschool Stereoacuity test (Stereo Optical Co., Inc, Illinois, USA) Test distance: 40 cm Test disparities: 800, 400, 200, 100, 60, and 40 arcseconds Procedure: The subject identifies shapes at 40 cm. Record the smallest disparity at which the subject correctly identifies at least two of the three shapes. If unable to identify the largest disparity (800 arcsec), record as "nil stereo" (log stereoacuity value: 3.2 log arcsec).
Time frame: From enrollment to the end of follow-up at 1 year
Newcastle Control Score (NCS) score incorporates both objective and subjective measures of control into a simple grading system that differentiates and quantifies the various levels of severity in intermittent distance exotropia.
Minimum and maximum values: Minimum 0, maximum 9. Interpretation of higher scores: Higher scores indicate worse control (i.e., worse outcome). A score of 0 represents perfect control, while a score of 9 represents the poorest control (constant exotropia or severe loss of control).
Time frame: From enrollment to the end of follow-up at 1 year
Strabismic deviation is measured by using the prism and alternate cover test (PACT) with accommodative targets at distance (6 m) and near (33 cm), measured after 1 hour of monocular occlusion using prisms, where the endpoint is defined as no eye movement during alternate cover testing.
Time frame: From enrollment to the end of follow-up at 1 year
Equipment: Near point rule Procedure: A target is moved gradually toward the center of the subject's eyes at a speed of 1 cm/s until the subject reports double vision or the examiner observes an outward deviation of one eye. The distance from the target to the spectacle plane is recorded as the NPC distance in centimeters.
Time frame: From enrollment to the end of follow-up at 1 year
Equipment: Synoptophore (Haag Streit UK Ltd, Essex, UK) Targets: Fusion slides subtending a visual angle of 6 degrees horizontally Procedure: First, the subject moves the synoptophore arms by themselves to overlap and fuse the images (e.g., a butterfly and a cat). The examiner then slowly abducts or adducts the synoptophore tubes until the subject sees two distinct images (breakpoint). The range between the two breakpoints is recorded as the fusional vergence amplitude.
Time frame: From enrollment to the end of follow-up at 1 year
Method: Far gradient method Test distance: 6 meters Stimulus: Minus lenses (-3.00 D) Procedure: A change in accommodation is stimulated using minus lenses. The resulting change in deviation (in prism diopters) is divided by the change in lens power (3 D). AC/A ratio = change in deviation / 3.
Time frame: From enrollment to the end of follow-up at 1 year
Measurement Tool: OCULUS Pentacam® (OCULUS Optikgeräte GmbH, Wetzlar, Germany), a rotating Scheimpflug camera system for anterior segment analysis Measurement Type: Continuous parameters of corneal topography, including curvature-derived parameters (anterior and posterior corneal curvature in diopters, D), elevation-derived parameters (anterior and posterior corneal elevation in micrometers, µm), and pachymetry-derived parameters (corneal thickness in micrometers, µm)
Unit of Measure:
Corneal curvature (keratometry, K1, K2, Kmax): Diopters (D) Corneal curvature radius: Millimeters (mm) Corneal thickness (pachymetry, CCT, thinnest point): Micrometers (µm) Corneal elevation: Micrometers (µm)
Time frame: From enrollment to the end of follow-up at 1 year
Equipment: Near point rule (RAF rule) with a near visual acuity target (one line above the best corrected near visual acuity) Test distance: Starting from approximately 40 cm, moving gradually closer Procedure: The subject wears their distance refractive correction.Place the near target at 40 cm and ask the subject to keep it clear. Move the target toward the subject's eyes at a speed of approximately 1-2 cm/s until the subject reports sustained blur (cannot be made clear by further effort). Stop immediately and measure the distance from the target to the spectacle plane (in cm).
Time frame: From enrollment to the end of follow-up at 1 year
Eye Health Behavior Assessment Scale (EHBAS) [21] that developed by Chinese National Disease Control and Prevention Administration in 2023 will be used to assess the level of eye health behaviors in children. It consists of two scales, Eye Health Behavior Assessment Scale for Kindergarten and Primary School Students in Grades 1-3 -Parent Version (EHBAS-P) and Eye Health Behavior Assessment Scale for Primary School. The content of the scale mainly includes various items such as exposure to natural light, outdoor activity time, digital screen time, reading posture and environment, and sleep time. The Scale was calculated using a score of 0 for 'cannot do it', 1 for 'sometimes do it' and 2 for 'do it'. Based on the sum of the scale's scores, the eye health behaviors of children and adolescents were classified into three levels: poor, moderate and good.
Contact information is provided by the study sponsor or research team.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06762067
Cranial Nerve Diseases, Exercise Training
View Trial DetailsNCT06594666
Intermittent Exotropia, Visual Functions
View Trial DetailsNCT02807350
Intermittent Exotropia
Birmingham, Alabama, United States
View Trial DetailsNCT05462821
Intermittent Exotropia
Birmingham, Alabama, United States
View Trial Details